Location History:
- Kviv, UA (2013 - 2015)
- Kiev, UA (2017 - 2019)
Company Filing History:
4 out of 525 
3 out of 3 
3 out of 560 
Years Active: 2013-2019
Title: Ramziya Kiyamova: A Pioneer in Cancer Immunotherapy
Introduction
Ramziya Kiyamova is a prominent inventor located in Kyiv, Ukraine, known for her significant contributions to cancer research and immunotherapy. With a total of four patents to her name, she has been at the forefront of developing innovative therapeutic strategies that harness the power of antibodies to target specific cancer markers.
Latest Patents
Kiyamova's latest patents focus on antibodies directed to the membrane transporter NaPi2b (SLC34A2) and their applications in cancer therapy. One of her notable inventions identifies the SLC34A2 epitope peptide, which spans amino acids 312-340 of SLC34A2, as a significant target for ovarian cancer treatment using the monoclonal antibody MX35. The patent outlines methods for generating antibodies with anti-tumor activities, as well as strategies to stimulate an immunological response. Additionally, her work provides assays for screening and identifying compounds that target the SLC34A2 epitope peptide and related antibodies, indicating a powerful approach to cancer treatment.
Career Highlights
Throughout her career, Kiyamova has worked with renowned institutions such as the Ludwig Institute for Cancer Research Limited and the Institute of Molecular Biology and Genetics of the National Academy of Sciences of Ukraine. Her research has been instrumental in paving the way for new immunotherapeutic options in the fight against cancer, showcasing her commitment to developing effective treatments.
Collaborations
Kiyamova has had the opportunity to collaborate with esteemed colleagues, including Gerd J Ritter and Beatrice Yin. These collaborations have allowed her to exchange ideas and broaden her research impact in the field, leading to groundbreaking discoveries in cancer therapy.
Conclusion
Ramziya Kiyamova's contributions to cancer immunotherapy through her innovations and patents significantly enhance our understanding of cancer treatment. Her work continues to inspire future research, and her collaborations and career achievements reflect her dedication to advancing medical science. As the field progresses, her inventions will likely play a crucial role in the development of targeted therapies for cancer patients worldwide.